Antihypertensive efficacy and safety of perindopril in mild-to-moderate essential hypertension: Results of a double-blind multicenter study versus atenolol

Efficacy And Safety ◽

Double Blind

A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension

Clinical Therapeutics ◽

10.1016/j.clinthera.2016.04.005 ◽

2016 ◽

Vol 38 (6) ◽

pp. 1485-1497 ◽

Cited By ~ 6

Author(s):

Jang Hoon Lee ◽

Dong Heon Yang ◽

Jin Yong Hwang ◽

Seung Ho Hur ◽

Tae Joon Cha ◽

...

Keyword(s):

Clinical Trial ◽

Essential Hypertension ◽

Group Comparison ◽

Efficacy And Safety ◽

Double Blind ◽

Parallel Group

A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: The MAPAVEL study

Clinical Therapeutics ◽

10.1016/s0149-2918(02)85010-x ◽

2002 ◽

Vol 24 (1) ◽

pp. 126-138 ◽

Cited By ~ 24

Author(s):

Antonio Coca ◽

Carlos Calvo ◽

Juan García-Puig ◽

Blas Gil-Extremera ◽

Maria T Aguilera ◽

...

Keyword(s):

Blood Pressure ◽

Essential Hypertension ◽

Ambulatory Blood Pressure Monitoring ◽

Ambulatory Blood Pressure ◽

Blood Pressure Monitoring ◽

Efficacy And Safety ◽

Pressure Monitoring ◽

Double Blind ◽

Blind Comparison

Double-blind efficacy and safety comparison of imidapril and hydrochlorothiazide in mild to moderate essential hypertension in the elderly.

American Journal of Hypertension ◽

10.1016/0895-7061(96)82079-6 ◽

1996 ◽

Vol 9 (4) ◽

pp. 175A

Author(s):

I DEWS

Keyword(s):

Essential Hypertension ◽

The Elderly ◽

Efficacy And Safety ◽

Double Blind

Double-Blind Comparison of the Efficacy and Safety of Trandolapril 2 mg and Hydrochlorothiazide 25 mg in Patients with Mild-to-Moderate Essential Hypertension

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199406001-00015 ◽

1994 ◽

Vol 23 ◽

pp. S77-80 ◽

Cited By ~ 7

Author(s):

B. H. Meyer ◽

N. C. Pauly

Keyword(s):

Essential Hypertension ◽

Efficacy And Safety ◽

Double Blind ◽

Blind Comparison

ANTIHYPERTENSIVE EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL AND RAMIPRIL IN ELDERLY PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION: THE ESPORT STUDY: HT.1.03

Journal of Hypertension ◽

10.1097/01.hjh.0000378322.03393.4a ◽

2010 ◽

Vol 28 ◽

pp. e45-e46

Author(s):

E Malacco ◽

S Omboni ◽

M Volpe ◽

A Auteri ◽

A Zanchetti

Keyword(s):

Essential Hypertension ◽

Elderly Patients ◽

Olmesartan Medoxomil ◽

Efficacy And Safety

PS 17-77 A RANDOMIZED, DOUBLE-BLIND AND DOUBLE-DUMMY, MULTIPLE-DOSE, POSITIVE AND PARALLEL COMPARATIVE, MULTICENTER CLINICAL TRIAL OF ALLISARTAN EVALUATE EFFICACY AND SAFETY IN PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION

Journal of Hypertension ◽

10.1097/01.hjh.0000501337.63990.a6 ◽

2016 ◽

Vol 34 (Supplement 1) ◽

pp. e495-e496

Author(s):

Zhiyi Ma ◽

Hongyi Wang ◽

Shan Jing ◽

Yuanyuan Chen ◽

Yang Xi ◽

...

Keyword(s):

Clinical Trial ◽

Essential Hypertension ◽

Multiple Dose ◽

Efficacy And Safety ◽

Multicenter Clinical Trial ◽

Double Blind

A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: The Iberian Multicenter Imidapril study on hypertension (IMISH)

Clinical Therapeutics ◽

10.1016/j.clinthera.2006.12.006 ◽

2006 ◽

Vol 28 (12) ◽

pp. 2040-2051 ◽

Cited By ~ 9

Author(s):

Jose Luis Palma Gámiz ◽

Mariano Pêgo ◽

Emilio Márquez Contreras ◽

Montserrat Pujol Anglada ◽

Josefina Oliván Martinez ◽

...

Keyword(s):

Essential Hypertension ◽

Adult Patients ◽

Double Blind ◽

Noninferiority Trial ◽

Parallel Group

Double-Blind Comparison of the Efficacy and Safety of Trandolapril 2 mg and Hydrochlorothiazide 25 mg in Patients with Mild-to-Moderate Essential Hypertension

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199400234-00015 ◽

1994 ◽

Vol 23 ◽

pp. S77-80 ◽

Cited By ~ 1

Author(s):

B. H. Meyer ◽

N. C. Pauly

Keyword(s):

Essential Hypertension ◽

Efficacy And Safety ◽

Double Blind ◽

Blind Comparison

Doxazosin for the Treatment of Benign Prostatic Hyperplasia in Patients with Mild to Moderate Essential Hypertension: A Double-Blind, Placebo-Controlled, Dose-Response Multicenter Study

The Journal of Urology ◽

10.1016/s0022-5347(01)67243-4 ◽

1995 ◽

Vol 154 (1) ◽

pp. 110-115 ◽

Cited By ~ 121

Author(s):

Jay Y. Gillenwater ◽

Richard L. Conn ◽

Steven G. Chrysant ◽

Johnny Roy ◽

Michael Gaffney ◽

...

Keyword(s):

Essential Hypertension ◽

Benign Prostatic Hyperplasia ◽

Dose Response ◽

Multicenter Study ◽

Prostatic Hyperplasia ◽

Double Blind ◽

Double Blind Placebo

548 A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL GROUP, ACTIVE CONTROLLED MULTI-CENTER CLINICAL TRIAL TO EVALUATE THE ADDITIONAL EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL/AMLODIPINE 20/5 MG IN CHINESE PATIENTS WITH MILD OR MODERATE ESSENTIAL HYPERTENSION WHO FAILED TO ACHIEVE THEIR GOAL WITH AMLODIPINE 5MG MONOTHERAPY

Journal of Hypertension ◽

10.1097/01.hjh.0000420822.48472.89 ◽

2012 ◽

Vol 30 ◽

pp. e161

Author(s):

Ping-Jin Gao ◽

Jun-Ren Zhu

Keyword(s):

Clinical Trial ◽

Essential Hypertension ◽

Olmesartan Medoxomil ◽

Chinese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Parallel Group